Müllerian Inhibiting Substance/anti-Müllerian hormone: a potential therapeutic agent for human ovarian and other cancers

Author： MacLaughlin David T   Donahoe Patricia K  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.6, Iss.3, 2010-03, pp. : 391-405

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Expression of Müllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer

By                    

International Journal of Oncology, Vol. 40, Iss. 6, 2012-01 ,pp. : 2013-2021

Spandidos Publications

Access to resources Recommend Favorite

Transcriptome analysis reveals that Müllerian inhibiting substance regulates signaling pathways that contribute to endometrial carcinogenesis

By                  

International Journal of Oncology, Vol. 46, Iss. 5, 2015-01 ,pp. : 2039-2046

Spandidos Publications

Access to resources Recommend Favorite

Benign Müllerian Papilloma of Childhood

By Mierau Gary   Lovell Mark   Wyatt-Ashmead Josephine   Goin Luann  

Ultrastructural Pathology, Vol. 29, Iss. 3-4, 2005-05 ,pp. : 209-216

Informa Healthcare

Access to resources Recommend Favorite

Pegylated liposomal doxorubicin for platinum-resistant or refractory Müllerian carcinoma (epithelial ovarian carcinoma, primary carcinoma of Fallopian tube and peritoneal carcinoma): A single-institutional experience

By                    

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 35-38

Spandidos Publications

Access to resources Recommend Favorite

Doxycycline as Potential Anti-cancer Agent

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 17, Iss. 12, 2018-01 ,pp. : 1617-1623

Bentham Science Publishers

Access to resources Recommend Favorite